Hossam Taha Mohamed

Syndecan-1 is a novel molecular marker for triple negative inflammatory breast cancer and modulates the cancer stem cell phenotype via the IL-6/STAT3, Notch and EGFR signaling pathways

Sherif Ibrahim, Ramy Gadalla, Eslam A. Elghonaimy et al. · Molecular Cancer · 2017 · 277 citations · Full text

Medicine, Cancer Biology, Oncology +17

Inflammatory breast cancer: Activation of the aryl hydrocarbon receptor and its target CYP1B1 correlates closely with Wnt5a/b-β-catenin signalling, the stem cell phenotype and disease progression

Hossam Taha Mohamed, Ramy Gadalla, Noura El-Husseiny et al. · Journal of Advanced Research · 2018 · 72 citations · Full text

Medicine, Cancer Biology, Oncology +17

Human Cytomegalovirus Infection Enhances NF-κB/p65 Signaling in Inflammatory Breast Cancer Patients

Mohamed El‐Shinawi, Hossam Taha Mohamed, Eslam A. Elghonaimy et al. · PLoS ONE · 2013 · 69 citations · Full text

Medicine, Immunology, Oncology +12

Antiviral Activity of Chitosan Nanoparticles Encapsulating Curcumin Against Hepatitis C Virus Genotype 4a in Human Hepatoma Cell Lines

Samah A. Loutfy, Mostafa H. Elberry, Khaled Y. Farroh et al. · Dove Medical Press (Taylor and Francis Group) · 2020 · 54 citations · Full text

Pharmacy, Infectious Diseases, Materials Science +17

IL-8 secreted by tumor associated macrophages contribute to lapatinib resistance in HER2-positive locally advanced breast cancer via activation of Src/STAT3/ERK1/2-mediated EGFR signaling

Shaza Ahmed, Hossam Taha Mohamed, Noura El-Husseiny et al. · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · 2021 · 49 citations

Medicine, Cancer Biology, Oncology +14